Literature DB >> 2554488

Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.

S Matsuda1, M Gidlund, F Chiodi, A Cafaro, A Nygren, B Morein, K Nilsson, E M Fenyö, H Wigzell.   

Abstract

Low concentrations of serum obtained from a patient with acquired immunodeficiency syndrome (AIDS) enhanced the replication of human immunodeficiency virus type 1 (HIV-1) in a particular subclone of the CD-4-positive monocytoid cell line U937 clone 2. Cells of this subclone have a high expression of Fc receptors and a considerable degree of Fc-mediated phagocytic activity. IgG purified from the serum was also able to enhance the replication. These results indicate that low concentrations of human anti-HIV antibody may enhance HIV replication on human monocyte-macrophages. Furthermore, two mouse IgG1 monoclonal antibodies against gp120, the envelope glycoprotein of HIV-1, also induced enhancement at low concentrations. The binding of radiolabelled gp120 to the cells was increased at the same low concentrations. Antibodies against envelope glycoproteins may cause enhancement of HIV infection. Both normal and enhanced replication of HIV were completely inhibited by the masking of the binding site of CD4 molecules with F(ab')2 fragments of anti-CD4 antibody. Moreover, CD4-positive, Fc gamma RI-negative K562 cells and mouse macrophages failed to show any infection in the presence of antibody. These results suggest that CD4 molecules on the cell surface are necessary to cause enhancement of infection of HIV on monocyte-macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554488     DOI: 10.1111/j.1365-3083.1989.tb02446.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  M K Gorny; J Y Xu; V Gianakakos; S Karwowska; C Williams; H W Sheppard; C V Hanson; S Zolla-Pazner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.

Authors:  P P Shadduck; J B Weinberg; A F Haney; J A Bartlett; A J Langlois; D P Bolognesi; T J Matthews
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis.

Authors:  G T Spear; B L Sullivan; A L Landay; T F Lint
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement.

Authors:  J Laurence; A Saunders; E Early; J E Salmon
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

5.  CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

Authors:  N Thieblemont; N Haeffner-Cavaillon; A Ledur; J L'Age-Stehr; H W Ziegler-Heitbrock; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

6.  Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype.

Authors:  J Trial; H H Birdsall; J A Hallum; M L Crane; M C Rodriguez-Barradas; A L de Jong; B Krishnan; C E Lacke; C G Figdor; R D Rossen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120.

Authors:  A Takeda; J E Robinson; D D Ho; C Debouck; N L Haigwood; F A Ennis
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R.

Authors:  A Takeda; R W Sweet; F A Ennis
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro.

Authors:  F D Tóth; P Mosborg-Petersen; J Kiss; G Aboagye-Mathiesen; M Zdravkovic; H Hager; J Aranyosi; L Lampé; P Ebbesen
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

Review 10.  The virus-immunity ecosystem.

Authors:  P C Doherty; S J Turner
Journal:  Arch Virol Suppl       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.